Article

Effect of PCSK9 Inhibitors on Regulators of Lipoprotein Homeostasis, Inflammation and Coagulation

2024-12-31

Abstract excerpt

PCSK9 inhibitors (PCSK9i) represent a newer form of atherosclerosis treatment. Inflammation and haemostasis are key processes in the development of atherosclerosis. In this study, we investigated the influence of therapy with PCSK9i in patients with coronary artery disease (CAD) on regulators for lipoprotein homeostasis, inflammation and coagulation. Using quantitative polymerase chain reaction (qPCR) we measured...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 59c43057-4570-54ac-8273-a59dbe474e91
DOI: 10.20944/preprints202412.2573.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effect of PCSK9 Inhibitors on Regulators of Lipoprotein Homeostasis, Inflammation and CoagulationDOI 10.20944/preprints202412.2573.v1Read

PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosisSemantic proximity Read

PCSK9 Inhibitors: Pharmacology and Therapeutic PotentialSemantic proximity Read

PCSK9: a key modulator of cardiovascular health.Semantic proximity Read

WITHDRAWN: Deciphering PCSK9 and LDLR Gene Expression in Coronary Artery Disease Patients: Implications for Blood Lipid RegulationSemantic proximity Read

Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.Semantic proximity Read

PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes.Semantic proximity Read

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.Semantic proximity Read

Inclisiran—Silencing the Cholesterol, Speaking up the PrognosisSemantic proximity Read

Targeting PCSK9 for the treatment of hypercholesterolemia.Semantic proximity Read

Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor TherapySemantic proximity Read

Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population.Semantic proximity Read

Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes.Semantic proximity Read